...
首页> 外文期刊>Clinical and applied thrombosis/hemostasis >Reduced immunogenic potential of membrane filtered bovine thrombin preparations for hemostatic application.
【24h】

Reduced immunogenic potential of membrane filtered bovine thrombin preparations for hemostatic application.

机译:膜过滤牛凝血酶制剂用于止血应用的免疫原性降低。

获取原文
获取原文并翻译 | 示例

摘要

There is concern that exposure to bovine thrombin can result in the development of antibodies, usually against factor V/Va, which can lead to hemostatic abnormalities. It is thought that purer preparations of bovine thrombin might be less immunogenic. Utilizing newer methods including a membrane filtration step, bovine crude thrombin is further purified into thrombin 4A and 4B preparations which exhibit a higher specific activity and are devoid of some of the protein contaminants. Bovine crude thrombin and its purified versions were administered intravenously to individual groups of rabbits using standard immunologic protocols. Antiserum was drawn from each rabbit and the pooled antisera were purified to obtain the IgGs using protein G affinity columns. The results suggest that the reported purification process, including filtration, resulted in the removal of most of the antigens found in crude thrombin, and that none of these preparations generated any detectable antibodies against bovine factor V related antigens.
机译:令人担忧的是,暴露于牛凝血酶会导致抗体生成,通常是针对因子V / Va的抗体,这会导致止血异常。认为较纯的牛凝血酶制剂可能具有较低的免疫原性。利用包括膜过滤步骤在内的新方法,将牛粗凝血酶进一步纯化为凝血酶4A和4B制剂,这些制剂表现出更高的比活度,并且不含某些蛋白质污染物。使用标准免疫学方案将牛粗凝血酶及其纯化形式静脉内施用于各组兔子。从每只兔子中提取抗血清,并使用蛋白G亲和柱纯化合并的抗血清以获得IgG。结果表明,报道的纯化过程(包括过滤)导致除去了粗凝血酶中发现的大多数抗原,而且这些制剂均未产生任何可检测到的针对牛V因子相关抗原的抗体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号